Evidence-based recommendations for the diagnosis and treatment of paediatric acne

Archives of Disease in Childhood: Education and Practice Edition

Volumn 99, Issue 4, 2014, Pages 135-137

  Lee, Kachiu C ^a   Lio, Peter A ^b  

^a BROWN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE PLUS BENZOYL PEROXIDE; AZITHROMYCIN; CEFALEXIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; DOXYCYCLINE; MINOCYCLINE; RETINOIC ACID; TAZAROTENE;

ACNE; ACNE VULGARIS; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL INFORMATION; METHODOLOGY; PRACTICE GUIDELINE; REVIEW; CHILD; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; PATIENT REFERRAL; PROCEDURES; STANDARDS;

ACNE VULGARIS; CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION;

EID: 84908298062     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/archdischild-2013-305170     Document Type: Review

References (10)

1. Eichenfield LF, Krakowski AC, Piggott Caroline, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013;131:S163-86.
2. Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012;26(Suppl 1):1-29.
3. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993;341:1181-2.
4. Marqueling AL, Zane LT. Depression and suicidal behaviour in acne patients treated with isotretinoin: a systemic review. Semin Cutan Med Surg 2007;26:210-20.
5. Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort. Can J Clin Pharmacol 2007;14:e227-33.
6. Rehn LM, Meririnne E, Hook-Nikanne J, et al. Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts. J Eur Acad Dermatol Venereol 2009;23:1294-7.
7. McGrath EJ, Lovell CR, Gillison F, et al. A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms. Br J Dermatol 2010;163:1323-9.
8. Tekin NS, Ozdolap S, Sarikaya S, et al. Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne. Int J Dermatol 2008;47:622-5.
9. Alhusayen RO, Juurlink DN, Mamdani MM, et al. Isotretinoin use and the risk of inflammatory bowel disease: a population-based study. J Invest Dermatol 2013;133:907-12.
10. Etminan M, Bird ST, Delaney JA. Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. JAMA Dermatol. 2013;149:216-20.